Funding Rounds
Oncopeptides

Oncopeptides Unknown (2022, $31M)

Oncopeptides

Innovative therapy for difficult-to-treat hematological diseases.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Unknown

Raised Amount: $31.24M

Investors